#cholesterol
7 stories
Novartis and Ionis Cholesterol Drug Fails Trial
Novartis and Ionis' cholesterol drug failed to reduce heart attacks in late-stage trial.
Yahoo Finance · 1m
Cholesterol Guidelines Personalize Treatment
New cholesterol guidelines target individual risk to prevent heart disease.
PhillyVoice · 1m
New cholesterol guidelines personalize your heart risk
Updated 2026 guidelines shift cholesterol treatment toward earlier screening and personalized plans based on your unique risk factors.
The Conversation · 3m
Two slices of wholegrain bread a day could transform your heart health
Major study finds simple dietary change linked to weight loss, lower cholesterol and reduced heart attack risk.
Dailymail · 2m · 6 views
Are GLP-1s the New Statins?
Cardiologists say Ozempic protects the heart in ways that have little to do with the number on the scale.
Men's Health · 2m
He did everything right. His heart didn't care.
A half-marathoner with perfect habits had plaque in his arteries, and the numbers he was tracking never would have caught it.
Men's Health · 2m
The Lp(a) Drug That Missed
A blockbuster cholesterol drug just failed its big trial, and it may mean we've been aiming at the wrong target.
Men's Health · 1m